Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
PLoS One. 2013 Jul 29;8(7):e70392. doi: 10.1371/journal.pone.0070392. Print 2013.
RORα is a retinoid-related orphan nuclear receptor that regulates inflammation, lipid metabolism, and cellular differentiation of several non-epithelial tissues. In spite of its high expression in skin epithelium, its functions in this tissue remain unclear. Using gain- and loss-of-function approaches to alter RORα gene expression in human keratinocytes (HKCs), we have found that this transcription factor functions as a regulator of epidermal differentiation. Among the 4 RORα isoforms, RORα4 is prominently expressed by keratinocytes in a manner that increases with differentiation. In contrast, RORα levels are significantly lower in skin squamous cell carcinoma tumors (SCCs) and cell lines. Increasing the levels of RORα4 in HKCs enhanced the expression of structural proteins associated with early and late differentiation, as well as genes involved in lipid barrier formation. Gene silencing of RORα impaired the ability of keratinocytes to differentiate in an in vivo epidermal cyst model. The pro-differentiation function of RORα is mediated at least in part by FOXN1, a well-known pro-differentiation transcription factor that we establish as a novel direct target of RORα in keratinocytes. Our results point to RORα as a novel node in the keratinocyte differentiation network and further suggest that the identification of RORα ligands may prove useful for treating skin disorders that are associated with abnormal keratinocyte differentiation, including cancer.
RORα 是一种类视黄醇相关的孤儿核受体,可调节几种非上皮组织的炎症、脂质代谢和细胞分化。尽管它在上皮组织中的表达水平很高,但它在该组织中的功能仍不清楚。我们通过改变人角质形成细胞(HKCs)中 RORα 基因的表达的增益和缺失功能的方法,发现该转录因子是表皮分化的调节因子。在 4 种 RORα 异构体中,RORα4 以随分化而增加的方式在上皮细胞中高度表达。相比之下,皮肤鳞状细胞癌肿瘤(SCCs)和细胞系中的 RORα 水平显著降低。在 HKCs 中增加 RORα4 的水平可增强与早期和晚期分化相关的结构蛋白以及与脂质屏障形成相关的基因的表达。RORα 的基因沉默会损害角质形成细胞在体内表皮囊肿模型中分化的能力。RORα 的促分化功能至少部分是通过 FOXN1 介导的,FOXN1 是一种众所周知的促分化转录因子,我们确定其为角质形成细胞中 RORα 的新的直接靶基因。我们的研究结果表明 RORα 是角质形成细胞分化网络中的一个新节点,并进一步表明鉴定 RORα 配体可能有助于治疗与角质形成细胞分化异常相关的皮肤疾病,包括癌症。